Anatara Lifesciences Ltd · ASX:ANR
Anatara Lifesciences — Gold Coast Investment Showcase 2017
18 slides from Anatara Lifesciences's conference presentation, Jun 21, 2017
Slide 1: ASX Release: Anatara Investor Presentation
ASX Release Anatara Investor Presentation For personal use only BRISBANE, 21st June 2017: Anatara Lifesciences (ASX:ANR) is pleased to release to investors a copy of the presentation for the Gold Coast Investment Showcase (June 21st & 22nd 2017). A copy of the presentation is attached. For more info
Slide 2: Natural Alternative to Antibiotics
For personal use only Natural Alternative to Antibiotics June 2017
Slide 3: Disclaimer
Disclaimer For personal use only The information in this presentation does not constitute personal investment advice. The presentation is not intended to be comprehensive or provide all information required by investors to make an informed decision on any investment in Anatara Lifesciences Ltd, ACN
Slide 4: Key Financial Details
Key Financial Details For personal use only ASX Code Market Share Price1 Capitalisation ANR $50.9 million $1.03 Current Cash2 Ordinary Shares Share Price 49,413,236 up 142% $11 million since IPO 1. As at 15 June 2017 2. Appendix 4C - 31 March 2017 3
Slide 5: ANR Share Price Chart
ANR Share Price Chart For personal use only 4
Slide 6: Oral therapeutics for gastrointestinal disease in livestock and humans
Oral therapeutics for gastrointestinal disease in livestock and humans For personal use only Detach™ • Natural, safe, non-antibiotic therapeutic that prevents and treats gastrointestinal diseases, including diarrhoea • Meets the need to reduce the use of antibiotics and zinc oxide in animal producti
Slide 7: Need to combat antimicrobial resistance
Need to combat antimicrobial resistance For personal use only resistance to antibiotics ‘….the greatest and most urgent global risk’ General Assembly of the United Nations 2016 Antibiotic resistance driven by the overuse of antibiotics in humans and agriculture • Vast majority of antibiotics are use
Slide 8: Lead Indication – Pigs
Lead Indication – Pigs Diarrhoea affects hundreds of millions of piglets born each year For personal use only Millions of piglets weaned per year 20% more piglets die before weaning due to health issues 7
Slide 9: Market Opportunity is clear
Market Opportunity is clear For personal use only • DetachTM addresses a major need – the livestock industry need effective alternatives to antibiotics to prevent diarrhoea • Governments are banning antibiotics for growth promotion and restricting prophylactic use in animal production • Global anima
Slide 10: Consumer Pressure - Food Quality & Food Safety
Consumer Pressure - Food Quality & Food Safety For personal use only • McDonald's will stop buying chicken reared on antibiotics used in humans within two years (March 2015). • McDonald's is the largest restaurant chain in the world — this move had a major impact on other retailers and will now affe
Slide 11: Consumer Pressure
10 For personal use only Consumer Pressure
Slide 12: Detach
DetachTM For personal use only • Detach™ is an orally administered non- antibiotic alternative • Proven efficacy – evidence-based therapeutic claims • Proven safety – active ingredient is a natural plant based product • Broad acting – acts against a range of causes of diarrhoea • Stable - does not r
Slide 13: Detach - Poised for swift market entry
Detach™ - Poised for swift market entry Commercially validated, supported by demand For personal use only • A clear path to market: Launch in 2018 • Manufacturing complete at commercial scale and global supply confirmed • Introduction of DetachTM is supported by industry, government, retailer & cons
Slide 14: What Next? Detach - A Pipeline in a Product
What Next? Detach™ - A Pipeline in a Product For personal use only Other Detach™ presentations: – Livestock: in-feed – Livestock: in-water Potential product extensions for the core components of Detach™ Partnering Opportunities for: – Human GI conditions (diarrhoea; inflammatory bowel disease; irrit
Slide 15: Detach - leverage Pigs to People
Detach™ - leverage Pigs to People For personal use only 14
Slide 16: Human GI disorders/disease - Large patient populations
Human GI disorders/disease -Large patient populations For personal use only 15
Slide 17: Anatara Investment Overview
Anatara Investment Overview For personal use only • Experienced board and management team with proven track record • Lead product, Detach™, has a clear route to market – Commercially validated and proven efficacy – Development strategy de-risked and revenues within 2 years • Well funded – sufficient
Slide 18: Thank you
Thank you For personal use only “… the unnecessary use of antibiotics in animals and agriculture is a significant concern for human health… stopping the over-use of antibiotics – fed in vast quantities to animals for growth promotion as well as to treat disease, may be even more important than incen
Anatara Lifesciences — Gold Coast Investment Showcase 2017 on 6ix